American Society of Hematology, 2025 (ASH) 7 - 9 December 2025

Mim8 prophylaxis in adults and adolescents with Hemophilia A: 52-week efficacy and safety outcomes from the Phase 3 FRONTIER2 study

Authors :

Steven Lentz1, Aby Abraham2, Cihan Ay3, Anthony Chan4, Víctor Jiménez-Yuste5, Johannes Oldenburg6, Maria Elisa Mancuso7, 8, Johnny Mahlangu9, Tadashi Matsushita10, Lize van Vulpen11, Renchi Yang12, Amalie Rhode Høgh Nielsen13, Ilgiz Rakhmatullin13, Pratima Chowdary14

Affiliations
View Details Hide Details
PDF default button label
Keywords
Haemophilia
Congress oral presentation
Mim8